EGF receptor-targeted nanocarriers for enhanced cancer treatment.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Nanomedicine

• Publication date

  2012-12-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2217/nnm.12.160PMID 23249333PMCID PMC3607294
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer statistics, 2012

  2012cited by this paper
• EGFR-mediated intracellular delivery of Pc 4 nanoformulation for targeted photodynamic therapy of cancer: in vitro studies.

  2012cited by this paper
• Targeted radiotherapy for malignant gliomas.

  2012cited by this paper
• EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity.

  2012cited by this paper
• Nanoparticle delivery of a peptide targeting EGFR signaling.

  2012influential reference
• Image‐guided surgery in head and neck cancer: Current practice and future directions of optical imaging

  2012cited by this paper
• Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

  2012influential reference
• Reprint of "Nanobody--shell functionalized thermosensitive core-crosslinked polymeric micelles for active drug targeting".

  2011cited by this paper
• Interrogation of EGFR Targeted Uptake of TiO2 Nanoconjugates by X-ray Fluorescence Microscopy.

  2011influential reference
• Affibody-functionalized gold-silica nanoparticles for Raman molecular imaging of the epidermal growth factor receptor.

  2011cited by this paper
• Targeted human serum albumin nanoparticles for specific uptake in EGFR-Expressing colon carcinoma cells.

  2011cited by this paper
• Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles.

  2011cited by this paper
• Illuminating epidermal growth factor receptor densities on filopodia through plasmon coupling.

  2011cited by this paper
• Noncovalent functionalization of carbon nanovectors with an antibody enables targeted drug delivery.

  2011cited by this paper
• Lung cancer targeted Raman active phospholipid gold nanoparticles for ultrasensitive and specific molecular imaging and detection

  2011cited by this paper
• A biparatopic anti‐EGFR nanobody efficiently inhibits solid tumour growth

  2011cited by this paper
• Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells.

  2011cited by this paper
• The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect.

  2011cited by this paper
• Magnetite/CdTe magnetic–fluorescent composite nanosystem for magnetic separation and bio-imaging

  2011cited by this paper
• Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study

  2011cited by this paper
• Nanobody-shell functionalized thermosensitive core-crosslinked polymeric micelles for active drug targeting.

  2011cited by this paper
• Therapeutic Efficacy and Safety of Paclitaxel/Lonidamine Loaded EGFR-Targeted Nanoparticles for the Treatment of Multi-Drug Resistant Cancer

  2011cited by this paper
• Targeted multifunctional gold-based nanoshells for magnetic resonance-guided laser ablation of head and neck cancer.

  2011cited by this paper
• Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor.

  2011cited by this paper
• Multimodal Nanodiamond Drug Delivery Carriers for Selective Targeting, Imaging, and Enhanced Chemotherapeutic Efficacy

  2011cited by this paper
• A Novel Magneto-fluorescent Nano-bioprobe for Cancer Cell Targeting, Imaging and Collection

  2011cited by this paper
• Pharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer.

  2011cited by this paper
• EGFR targeted PLGA nanoparticles using gemcitabine for treatment of pancreatic cancer.

  2011cited by this paper
• Selective targeting of antibody conjugated multifunctional nanoclusters (nanoroses) to epidermal growth factor receptors in cancer cells.

  2011cited by this paper
• Specific targeting of nasopharyngeal carcinoma cell line CNE1 by C225-conjugated ultrasmall superparamagnetic iron oxide particles with magnetic resonance imaging.

  2011cited by this paper
• EGFR Signaling and Drug Discovery

  2010cited by this paper
• EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.

  2010cited by this paper
• HDL-mimicking peptide-lipid nanoparticles with improved tumor targeting.

  2010cited by this paper
• Growth Suppression of Human Hepatocellular Carcinoma Xenografts by a Monoclonal Antibody CH12 Directed to Epidermal Growth Factor Receptor Variant III*

  2010cited by this paper
• Preparation of EGFR monoclonal antibody conjugated nanoparticles and targeting to hepatocellular carcinoma

  2010cited by this paper
• Investigating the specific uptake of EGF-conjugated nanoparticles in lung cancer cells using fluorescence imaging

  2010cited by this paper
• Targeted core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin.

  2010cited by this paper
• Effect of surface properties on nanoparticle-cell interactions.

  2010cited by this paper
• Erlotinib in the treatment of non-small cell lung cancer: current status and future developments.

  2010cited by this paper
• Directed evolution of gold nanoparticle delivery to cells.

  2010cited by this paper
• Targeting EGFR-overexpressing tumor cells using Cetuximab-immunomicelles loaded with doxorubicin and superparamagnetic iron oxide.

  2010cited by this paper
• Use of nanoparticles for targeted, noninvasive thermal destruction of malignant cells.

  2010cited by this paper
• Delivery of the photosensitizer Pc 4 in PEG-PCL micelles for in vitro PDT studies.

  2010cited by this paper
• Aptamers as therapeutics

  2010cited by this paper
• Preparation of epidermal growth factor (EGF) conjugated iron oxide nanoparticles and their internalization into colon cancer cells

  2010cited by this paper
• Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin.

  2010cited by this paper
• Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response

  2009cited by this paper
• Development of targeted therapy with paclitaxel incorporated into EGF-conjugated nanoparticles.

  2009cited by this paper
• Cyclodextrin-covered gold nanoparticles for targeted delivery of an anti-cancer drug

  2009cited by this paper
• Smart Drug‐Loaded Polymer Gold Nanoshells for Systemic and Localized Therapy of Human Epithelial Cancer

  2009cited by this paper
• Novel peptide ligand directs liposomes toward EGF‐R high‐expressing cancer cells in vitro and in vivo

  2009cited by this paper
• Nanoparticles and cancer therapy: A concise review with emphasis on dendrimers

  2009cited by this paper
• Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy.

  2009cited by this paper
• How we got here, where we are going and being a cog in something turning.

  2009cited by this paper
• Targeting and imaging cancer cells by folate-decorated, quantum dots (QDs)- loaded nanoparticles of biodegradable polymers.

  2009cited by this paper
• Multifunctional block copolymer micelles for the delivery of 111In to EGFR-positive breast cancer cells for targeted Auger electron radiotherapy.

  2009cited by this paper
• Noninvasive monitoring of the fate of 111In-labeled block copolymer micelles by high resolution and high sensitivity microSPECT/CT imaging.

  2009cited by this paper
• Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice.

  2009cited by this paper
• Block Copolymer Micelles Conjugated with anti-EGFR Antibody for Targeted Delivery of Anticancer Drug

  2008cited by this paper
• Intracellular fate of a targeted delivery system

  2008cited by this paper
• Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in vivo.

  2008cited by this paper
• Molecular targeting in oncology

  2008cited by this paper
• Photothermal optical coherence tomography of epidermal growth factor receptor in live cells using immunotargeted gold nanospheres

  2008cited by this paper
• Epidermal Growth Factor Receptor-Targeted Gelatin-Based Engineered Nanocarriers for DNA Delivery and Transfection in Human Pancreatic Cancer Cells

  2008cited by this paper
• Clinical application of EGFR inhibitors in head and neck squamous cell cancer.

  2008cited by this paper
• Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer.

  2008cited by this paper
• Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging.

  2008cited by this paper
• In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy

  2008cited by this paper
• Molecular imaging of epidermal growth factor receptor in live cells with refractive index sensitivity using dark-field microspectroscopy and immunotargeted nanoparticles.

  2008cited by this paper
• In vitro efficacy of immuno-chemotherapy with anti-EGFR human Fab-Taxol conjugate on A431 epidermoid carcinoma cells

  2007cited by this paper
• Monoclonal antibody cetuximab binds to and down-regulates constitutively activated epidermal growth factor receptor vIII on the cell surface.

  2007cited by this paper
• Endocytic mechanisms for targeted drug delivery.

  2007cited by this paper
• Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells.

  2007cited by this paper
• Two-photon luminescence imaging of cancer cells using molecularly targeted gold nanorods.

  2007cited by this paper
• Construction of anti-EGFR immunoliposomes via folate-folate binding protein affinity.

  2007cited by this paper
• EGFR targeting of solid tumors.

  2007cited by this paper
• Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting.

  2007cited by this paper
• Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles.

  2006cited by this paper
• Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics

  2005cited by this paper
• Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer.

  2005cited by this paper
• Multitasking in Tumor Progression: Signaling Functions of Cell Adhesion Molecules

  2004cited by this paper
• Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells.

  2003cited by this paper
• Antiproliferative, antiangiogenic and proapoptotic activity of h‐R3: A humanized anti‐EGFR antibody

  2002cited by this paper
• Monoclonal antibodies to target epidermal growth factor receptor–positive tumors

  2002cited by this paper
• The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting.

  2001cited by this paper
• Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor

  2001cited by this paper
• Cancer statistics

  1989cited by this paper
• A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

  1986cited by this paper

• Platinum-based functional nanomaterials: mechanisms and therapeutic strategies in cancer radiotherapy sensitization

  2026cites this paper
• Effective Degradation of Wild‐Type and Mutant EGFR Using Self‐Assembling Peptide‐Derived PROTAC Nanoparticles (NanoTACs) for Cancer Therapy

  2025cites this paper
• Exploring the dual impact of nanoparticles on human well-being: A comprehensive review of risks and benefits

  2025cites this paper
• Antitumor efficacy achieved by targeting PEGylated nanomedicines to netrin-1 in the extracellular matrix or EphA2 on the cancer cell membrane.

  2025cites this paper
• The evolution of integrated magnetic hyperthermia and chemodynamic therapy for combating cancer: a comprehensive viewpoint

  2025cites this paper
• Breathing new life nanomedicines for pulmonary drug delivery: targeting approaches, experimental models, and regulatory aspects

  2025cites this paper
• Aptamers as therapeutic targets: prospects and progress in the treatment of cancers.

  2025cites this paper
• Surface receptor-targeted protein-based nanocarriers for drug delivery: advances in cancer therapy

  2025cites this paper
• Surface Functionalization of Nanocarriers with Anti-EGFR Ligands for Cancer Active Targeting

  2025cites this paper
• Bio-Functional Nanomaterials for Enhanced Lung Cancer Therapy: The Synergistic Roles of Vitamins D and K

  2025cites this paper
• PEGylated lipids in lipid nanoparticle delivery dynamics and therapeutic innovation

  2025cites this paper
• Role of nanoparticles in enhancing chemotherapy efficacy for cancer treatment

  2024cites this paper
• Development of a prototype of a theranostic system based on silica nanoparticles with immobilized fluorescent dyes and VEGF targeting ligand.

  2024cites this paper
• Receptor mediated targeting of EGF-conjugated alginate-PAMAM nanoparticles to lung adenocarcinoma: 2D/3D in vitro and in vivo evaluation.

  2024cites this paper
• Investigating the potential of zinc oxide nanoparticles and zinc ions as promising approaches to lung cancer

  2024cites this paper
• Direct Functionalization of Polysaccharide‐Based Xylan Phenyl Carbonate Nanoparticles with Tumor Cell Specific Antibodies

  2024cites this paper
• Targeted nanodelivery systems for personalized cancer therapy

  2024cites this paper
• Nanoformulations in the treatment of lung cancer: current status and clinical potential

  2024cites this paper
• Multifunctional gold nanoparticles for cancer theranostics

  2024cites this paper
• Advances in active targeting of ligand-directed polymeric nanomicelles via exploiting overexpressed cellular receptors for precise nanomedicine

  2024cites this paper
• Self-Assembled PEGylated Micelles for Precise and Targeted Drug Delivery: Current Challenges and Future Directions

  2024cites this paper
• Unleashing the promise of emerging nanomaterials as a sustainable platform to mitigate antimicrobial resistance

  2024cites this paper
• AICAR-loaded and panitumumab conjugated nanoparticles downregulate the expression of PD-L1 and enhance antitumor responses against ovarian cancer through the AMPK/STAT3 axis

  2024cites this paper
• EGFR Targeting of Liposomal Doxorubicin Improves Recognition and Suppression of Non-Small Cell Lung Cancer

  2024cites this paper
• Targeted acidosis mediated delivery of antigenic MHC-binding peptides

  2024cites this paper
• Clinical Trials for Oral, Inhaled and Intravenous Drug Delivery System for Lung Cancer and Emerging Nanomedicine-Based Approaches

  2023cites this paper
• Targeted Acidosis Mediated Delivery of Antigenic MHC-Binding Peptides

  2023cites this paper
• ROS-mediated anticancer effects of EGFR-targeted nanoceria.

  2023cites this paper
• Development of light and pH-dual responsive self-quenching theranostic SPION to make EGFR overexpressing micro tumors glow and destroy.

  2023cites this paper
• EGFR-targeted semiconducting polymer nanoparticles for photoacoustic imaging.

  2023cites this paper
• Cellular Uptake of Silica Particles Influences EGFR Signaling Pathway and is Affected in Response to EGF

  2023influential citation
• Biomimetic cell-derived nanocarriers in cancer research

  2022cites this paper
• Dual-receptor-targeted nanomedicines: emerging trends and advances in lung cancer therapeutics.

  2022cites this paper
• Immunoliposomes: A Targeted Drug Delivery System for Cancer Therapeutics and Vaccination.

  2022cites this paper
• Monoclonal Antibody Functionalized, and L-lysine α-Oxidase Loaded PEGylated-Chitosan Nanoparticle for HER2/Neu Targeted Breast Cancer Therapy

  2022cites this paper
• Nanodiamonds for Theragnostic: Manufacturing and Biomedical Applications

  2021cites this paper
• Development of New Targeted Inulin Complex Nanoaggregates for siRNA Delivery in Antitumor Therapy

  2021cites this paper
• A Review on Polymer and Lipid-Based Nanocarriers and Its Application to Nano-Pharmaceutical and Food-Based Systems

  2021cites this paper
• Surface engineered nanocarriers for the management of breast cancer.

  2021cites this paper
• Cetuximab-Ag2S quantum dots for fluorescence imaging and highly effective combination of ALA-based photodynamic/chemo-therapy of colorectal cancer cells.

  2021cites this paper
• Improved anti-cancer effect of epidermal growth factor-gold nanoparticle conjugates by protein orientation through site-specific mutagenesis

  2021cites this paper
• Nanotechnology for Diagnosis, Imaging, and Treatment of Head and Neck Cancer

  2021cites this paper
• Extracellular Vesicle Nanoarchitectonics for Novel Drug Delivery Applications.

  2021cites this paper
• Nanomedicines functionalized with anti-EGFR ligands for active targeting in cancer therapy: biological strategy, design and quality control.

  2021cites this paper
• Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer

  2021cites this paper
• The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors

  2021cites this paper
• Targeted Drug Delivery: Advancements, Applications, and Challenges

  2021cites this paper
• In silico studies of interactions of peptide-conjugated cholesterol metabolites and betulinic acid with EGFR, LDR, and N-terminal fragment of CCKA receptors

  2021cites this paper
• Development of active tumor targeting systems for delivery of siRNA and drugs into breast and colorectal cancer

  2020cites this paper
• Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies.

  2020cites this paper
• Antibody-Targeted Nanoparticles for Cancer Treatment

  2020cites this paper
• Synthesis and analysis of 64Cu-labeled GE11-modified polymeric micellar nanoparticles for EGFR-targeted molecular imaging in a colorectal cancer model.

  2020cites this paper
• Epidermal growth factor (EGF)-based activatable probe for predicting therapeutic outcome of an EGF-based doxorubicin prodrug.

  2020cites this paper
• EGFR-Binding Peptides: From Computational Design towards Tumor-Targeting of Adeno-Associated Virus Capsids

  2020cites this paper
• Anti-EGFR-mAb and 5-Fluorouracil conjugated Polymeric Nanoparticle for Colorectal Cancer.

  2020cites this paper
• Bivalent Peptide- and Chelator-Containing Bioconjugates as Toolbox Components for Personalized Nanomedicine.

  2019cites this paper
• HIF1α-siRNA and gemcitabine combination-based GE-11 peptide antibody-targeted nanomedicine for enhanced therapeutic efficacy in pancreatic cancers

  2019cites this paper
• Production, surface modification and biomedical applications of nanodiamonds: A sparkling tool for theranostics.

  2019cites this paper
• Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy

  2019cites this paper
• Nanotechnology Toward Treating Cancer

  2019cites this paper
• Nanotechnology in Targeted Drug Delivery and Therapeutics

  2019cites this paper
• pH/redox sensitive nanoparticles with platinum(iv) prodrugs and doxorubicin enhance chemotherapy in ovarian cancer

  2019cites this paper
• Chapter 9 Liposomal Nanoformulations as Current Tumor-Targeting Approach to Cancer Therapy

  2019cites this paper
• Multifunctional nanomedicines for targeting epidermal growth factor receptor in colorectal cancer

  2019cites this paper
• Biologically Targeted Photo-Crosslinkable Nanopatch to Prevent Postsurgical Peritoneal Adhesion.

  2019cites this paper
• Real-Time Label-Free Targeting Assessment and in Vitro Characterization of Curcumin-Loaded Poly-lactic-co-glycolic Acid Nanoparticles for Oral Colon Targeting

  2019cites this paper
• Apoptotic lysosomal proton sponge effect in tumor tissue by cationic gold nanorods.

  2019cites this paper
• Targeting Cancer Resistance via Multifunctional Gold Nanoparticles

  2019cites this paper
• Epidermal Growth Factor Receptor and Its Role in Pancreatic Cancer Treatment Mediated by Nanoparticles

  2019cites this paper
• Nanotechnological strategies involved in the targeted delivery of anticancer drugs

  2019cites this paper
• Gold Nanoparticles to Tackle Drug Resistance in Cancer

  2019cites this paper
• Quantitative Analysis of Dual-Ligand Adhesion by AFM with Triple Negative Breast Cancer Cells

  2019cites this paper
• Advances in targeted nanotherapeutics: From bioconjugation to biomimicry

  2018cites this paper
• Bioengineered cellular and cell membrane‐derived vehicles for actively targeted drug delivery: So near and yet so far

  2018cites this paper
• Targeted delivery of doxorubicin into tumor cells by nanostructured lipid carriers conjugated to anti-EGFRvIII monoclonal antibody

  2018cites this paper
• A review of nanoparticle photosensitizer drug delivery uptake systems for photodynamic treatment of lung cancer.

  2018cites this paper
• Applications of Aptamers in Cancer Therapy

  2018cites this paper
• Advances in Receptor‐Mediated, Tumor‐Targeted Drug Delivery

  2018cites this paper
• Nanomaterial interactions with biomembranes: Bridging the gap between soft matter models and biological context.

  2018cites this paper
• Potential applications and human biosafety of nanomaterials used in nanomedicine

  2018cites this paper
• Targeted and controlled drug delivery by multifunctional mesoporous silica nanoparticles with internal fluorescent conjugates and external polydopamine and graphene oxide layers.

  2018cites this paper
• Modulation of Hypoxia-Induced Chemoresistance to Polymeric Micellar Cisplatin: The Effect of Ligand Modification of Micellar Carrier Versus Inhibition of the Mediators of Drug Resistance

  2018influential citation
• Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review

  2018cites this paper
• Targeting murine leukemic stem cells by antibody functionalized mesoporous silica nanoparticles

  2018cites this paper
• Nanoparticle-cell interactions induced apoptosis: a case study with nanoconjugated epidermal growth factor.

  2018cites this paper
• Peer-reviewed version of the manuscript published in final form at Chemical Society Reviews (2018) Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications

  2018cites this paper
• Tumor-Targeted Nanoparticles Deliver a Vitamin D-Based Drug Payload for the Treatment of EGFR Tyrosine Kinase Inhibitor-Resistant Lung Cancer.

  2018cites this paper
• Targeting the leptin receptor: To evaluate therapeutic efficacy and anti-tumor effects of Doxil, in vitro and in vivo in mice bearing C26 colon carcinoma tumor.

  2018cites this paper
• Liposomal Nanoformulations as Current Tumor-Targeting Approach to Cancer Therapy

  2017cites this paper
• A Smart Responsive Dual Aptamers-Targeted Bubble-Generating Nanosystem for Cancer Triplex Therapy and Ultrasound Imaging.

  2017cites this paper
• Controlling and Monitoring Intracellular Delivery of Anticancer Polymer Nanomedicines.

  2017cites this paper
• PNC27 anticancer peptide as targeting ligand significantly improved antitumor efficacy of Doxil in HDM2-expressing cells.

  2017cites this paper
• Desenvolvimento de nanopartículas lipídicas sólidas no carreamento de extrato alcaloídico de Solanum lycocarpum e avaliação biológica in vitro em células de câncer de bexiga

  2017cites this paper
• GE11 Peptide as an Active Targeting Agent in Antitumor Therapy: A Minireview

  2017cites this paper
• Cancer Nanotechnology: Hopes and Hurdles

  2017cites this paper
• Elongated Nanoparticle Aggregates in Cancer Cells for Mechanical Destruction with Low Frequency Rotating Magnetic Field

  2017cites this paper
• Design of smart GE11-PLGA/PEG-PLGA blend nanoparticulate platforms for parenteral administration of hydrophilic macromolecular drugs: synthesis, preparation and in vitro/ex vivo characterization.

  2016cites this paper
• Synthesis of the Nontargeted Nanoconstructs Stabilized with DTDTPA or TDOTA and the Respective Peptide Conjugated and / or Radiolabeled Particles Bioconjugate Chemistry

  2016cites this paper
• The impact of nanoconjugation to EGF-induced apoptosis

  2016cites this paper
• Fabrication of an EGF modified nanodiamonds-based anti-cancer drug targeted delivery system and drug carrier uptake visualization by 3D Raman microscopy

  2016cites this paper